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Despite signiﬁcant advances in preventive cardiovascular medicine and therapy for acute and chronic
heart failure, cardiovascular diseases remain among the leading causes of death worldwide. In recent
years cardiac tissue engineering has been established as a possible future treatment option for cardiac
disease. However, the quality of engineered myocardial tissues remains poor. In tissue engineering it is
important that the scaffold allows cells to attach, spread, maintain their differentiation status or
differentiate into functional cells in order to exhibit their physiological function. Here, we have inves-
tigated the suitability of the natural cardiac extracellular matrix component nephronectin as an adhesive
material for cardiac tissue engineering. Primary neonatal rat cardiomyocytes were seeded on collagen-,
ﬁbronectin- or nephronectin-coated glass coverslips and analyzed for cell adhesion, cellular metabolic
activity, response to extracellular stimuli, cell-to-cell communication, differentiation and contractility.
Our data demonstrate that most neonatal cardiomyocytes attached in an RGD domain-dependent
manner within 18 h to nephronectin. The cells exhibited high metabolic activity, responded to growth
factor stimuli and maintained their differentiation status. Moreover, nephronectin promoted sarcomere
maturation and alignment, cell-to-cell communication and synchronous contractions. In conclusion, our
ﬁndings demonstrate that nephronectin has excellent properties for cardiomyocyte adhesion and
function and thus has the potential to improve current cardiac tissue engineering approaches.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Cardiovascular diseases (CVDs) represent a major socio-
economic burden. They are responsible for around 30% of death
worldwide claiming as many lives as cancer, chronic lower respi-
ratory diseases, accidents and diabetes combined. The estimated
cost of CVD in 2008 was US$ 297.7 billion in the US alone
accounting for around 16% of the total health expenditures and the
future burden of heart disease is expected to further increase [1].
The primary cause ofmost CVDs is reduced heart function due to
the irreversible loss of heart muscle cells, the cardiomyocytes
[2e4]. The mammalian heart cannot regenerate and a possible
endogenous regenerative capacity can so far not be enhanced to
generate enough cardiomyocytes to improve heart function after
injury [5]. The only available therapy to effectively replace damaged
hearts is at the moment heart transplantation. Unfortunately, there
are not enough donor hearts to match the demand [6,7]. Therefore,x: þ49 6032 705211.
ngel).
-NC-ND license.it is critically important to develop technologies aimed at providing
new cardiomyocytes to diseased hearts.
One approach to reverse heart disease is the application of stem
cells. In the past it has been proven that transplanted fetal and
neonatal cardiomyocytes could functionally integrate and enhance
recipient cardiac function. Thus, multiple stem cell types have been
tested for re-population of the injured myocardium. However,
there appears little or no differentiation of the engrafted cells into
cardiomyocytes in vivo [8e10]. In addition, injection of stem cells in
the heart muscle causes severe cell loss due to shear stress. Injec-
tion in the blood circulation requires a homing signal to the
damaged tissue, which is still elusive. One solution to this problem
might be the integration of tissue engineering and stem cell biology
towards creating functional heart muscle in vitro [11,12]. The
engineered tissue can be adjusted according to the needs of
a patient before implantation andmaterials used as scaffolds might
enhance cardiomyocyte differentiation. Importantly, it has been
shown that engineered cardiac tissue based on type I collagen gel,
Matrigel and primary rat postnatal cardiomyocytes improves LV
function after myocardial infarction [13]. However, the used
material appears in its present form not suitable for clinical
C. Patra et al. / Biomaterials 33 (2012) 4327e43354328application. Thus, there is a need for other scaffold materials or
modiﬁcations of existing scaffolds [14,15].
It has been shown that the natural cardiac extracellular matrix
(ECM) after decellularization is suitable to engineer cardiac tissue
[16]. It provides adhesion substrates, imparts structural support,
stores and sequesters soluble factors, and transduces mechanical
signals [17]. In addition, it plays an important role in directing
tissue formation during development. For this reason, it is impor-
tant to deﬁne natural components of the cardiac ECM during
development and to analyze their properties. In the future this
might help to engineer scaffolds by incorporating ECM-derived
peptides into biomaterials to mimic biochemical signals required
to form complex cardiac tissue patches [15].
Recently, we have discovered nephronectin (Npnt) as a tran-
siently expressed ECM protein regulating valve formation during
cardiac development [18]. It contains an N-terminal signal peptide
followed by EGF-like repeats, an RGD sequence and a C-terminal
MAM domain [19]. Nephronectin is expressed in cardiomyocytes
throughout the heart and is secreted into the cardiac jelly, which is
in direct contact to cardiomyocytes and endocardial cells [18]. The
presence of an RGD sequence suggest that it will affect car-
diomyocyte behavior as it has been demonstrated that RGD
immobilization in an alginate scaffold increased neonatal rat car-
diomyocyte adhesion, prevented cell apoptosis and accelerated
cardiac tissue regeneration [20]. Besides its importance for valve
formation Npnt has been shown to play a role in kidney develop-
ment [21], arrector pili muscle formation [22] and osteoblast
differentiation [23]. However, the function of Npnt remains poorly
understood.
In this study we have investigated the potential of Npnt as an
adhesionmolecule for 3-days-old cardiac cells by analyzing cellular
metabolic activity, cell-to-cell communication, cell cycle activity,
differentiation status and contractility. For comparison we utilized
gelatin and ﬁbronectin.
2. Materials and methods
2.1. Rat neonatal cardiac cell isolation and cell culture
Animal experiments were approved by the local Committee for Care and Use of
Laboratory Animals (Regierungspräsidium Darmstadt, Gen. Nr. B 2/202) and
conform to the Guide for the Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Cardiac
cells were isolated from 3-days-old Sprague Dawley rats as previously reported [24].
Cardiomyocytes were enriched by preplating for 2 h (2mM L-glutamine, 10% FBS and
100 U/mg/ml Pen/Strep in DMEM/F12 medium). Non-attached cells were collected,
centrifuged, resuspended in neonatal cardiomyocyte medium (3 mM Na pyruvate,
2 mM L-glutamine, 0.1 mM ascorbic acid, 1 mg/ml insulin/transferrin/selenium, 0.2%
BSA and 100 U/mg/ml Pen/Strep in DMEM/F12 medium) supplemented with 5%
horse serum and seeded in a 24-well plate at 500 ml per well for 48 h if not stated
otherwise. Cells were cultured at 37 C in a 5% CO2/95% air humidiﬁed atmosphere.
2.2. Coating procedure for cell culture
Cells were cultured on coated glass coverslips (B 12 mm, Karl Hecht GmbH,
Germany), which were placed in 24-well tissue culture plates. Before coating
coverslips were treated once with 70% ethanol for 5 min and twice with 100%
ethanol for 3 min. For gelatin coating air-dried coverslips were incubated with 1%
(w/v) gelatin (Sigma)/water for 2 h at 37 C. Gelatin was afterwards aspirated and
coverslips were treated for 30 min with UV light. For Npnt (R&D Systems GmbH,
Germany) and ﬁbronectin (PromoCell, Germany) coating, air-dried coverslips were
incubated 2 h with 100 ml of 10 mg/ml ﬁbronectin or Npnt in PBS at 37 C. Cells were
seeded immediately after the aspiration of the protein solutions.
2.3. Immunocytochemistry
Cells were ﬁxedwith 3.7% formaldehyde (Sigma) for 15min. Different antibodies
were diluted in blocking buffer (5% goat serum, 0.2% Tween-20 in PBS), and all steps
were carried out at room temperature. For permeabilization, samples were treated
with 0.5% Triton X-100/PBS for 10 min. BrdU incorporation assays were performed
by incubating permeabilized cells in 2 N HCl/1%Triton X-100 for 30 min. Sampleswere blocked with blocking buffer for 20 min and incubated for 1 h with primary
antibodies (mouse monoclonal anti-a-smooth muscle actin, 1:100, Sigma; mouse
monoclonal anti-sarcomeric a-actinin; rat monoclonal anti-BrdU, 1:100, Abcam;
rabbit polyclonal anti-connexin 43, anti-troponin I, 1:50, Santa Cruz Biotechnology,
and rat monoclonal anti CD31, 1:50, BD Pharmingen). Either ALEXA 488- or ALEXA
594-conjugated antibodies (1:200, Molecular Probes) were used to detect immune
complexes. 40 ,60-diamidino-2-phenylindole (DAPI, Sigma) (0.5 mg/mL PBS) was used
to visualize DNA. Isolectin staining was performed on live cells as previously
described [25]. Brieﬂy, cells were washed with 10% FCS supplemented PBS (FCS-
PBS), incubated for 30 min on ice with Alexa 488 conjugated Isolectin (20 mg/ml,
Molecular probes, Germany)/FCS-PBS, again washed in FCS-PBS and analyzed. All
images were captured using a Leica ﬂuorescence microscope.
2.4. Cell attachment assay
Protein coated glass coverslips were seeded with 1.2  105 cells in 500 ml
neonatal medium supplemented with 5% HS. After 6, 18 and 48 h the number of
attached cells was quantiﬁed by calculating the average number of attached cells
from 10 randomly chosen microscopic ﬁelds for each independent experiment.
2.5. Cellular metabolic activity
In order to determine the cell viability and cytocompatibility of different
matrices 0.4  105 cardiomyocyte-enriched cardiac cells were seeded and cultured
for up to 8 days with media changes on every second day. Metabolic activity was
determined by MTT assays (Sigma) after 2, 4, 6 and 8 days of culture.
2.6. Integrin receptors blocking assays
Cardiomyocyte-enriched cells were incubated for 30minwith 300 mMof an Arg-
Gly-Glu-Ser (RGES) peptide (American peptide Company, Sunnyvale, CA) as control
or an Arg-Gly-Asp-Ser (RGDS) peptide (Calbiochem, La Jolla, CA) at 37 C [26].
Afterward cells were allowed to attach either for 24 h or 48 h.
2.7. Cell cycle activity
In order to analyze cell cycle activity coated coverslips were seeded with
0.8  105 cells for 48 h. Subsequently, cells were cultured for another 2 days in
neonatal medium and stimulated either with 5% horse serum or with a single
treatment of 50 ng/mL FGF1 (R&D Systems) and everyday treatment of 10 mM SB
203580 HCl (p38i) (Tocris). BrdU (30 mM, Sigma) was added for the last 24 h. Cell
cycle activity was quantiﬁed after 48 h of stimulation by counting 500 to 700 car-
diomyocytes from 6 to 9 randomly chosen microscopic ﬁelds for each independent
experiment.
2.8. Video image analysis
Cardiomyocytes were cultured with 5% HS on different matrices. Movies of
beating cardiomyocytes at day 2 were recorded with a Sony HDR-SR12 camcorder
and formatted (Wondershare or iSkysoft video converter).
2.9. RNA isolation and gene expression analysis
Total RNA was extracted from cardiomyocyte-enriched cells after 2 days of
culture on different matrices by RNeasy mini kit (Qiagen, Germany). cDNA was
synthesized by using random hexamer (Fermentas) following standard protocol.
Quantitative RT-PCR ampliﬁcation was performed in a single color real time poly-
merase chain reaction system using iQSYBR Green Supermix (Bio-Rad) and primer
pairs mentioned in Supplemental Table 1. Semi-quantitative polymerase chain
reaction was performed with the same primers following standard protocols.
2.10. Statistical analysis
Data are presented as the mean  SEM of at least three independent experi-
ments. Statistical signiﬁcance of differences was evaluated by one way ANOVA fol-
lowed by Bonferroni’s post-hoc test (GraphPad Prism). p < 0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Attachment of cardiac cells
One important criteria for scaffolds used in tissue engineering is
their attachment properties. Thus, we cultured 3-days-old post-
natal rat cardiomyocytes on nephronectin (Npnt) and determined
its adhesive properties. As positive control served ﬁbronectin,
a natural cardiac ECM component and established surface coating
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a negative control as it has poor adhesive properties.
Quantitative analysis of attached cardiac cells after
cardiomyocyte-speciﬁc staining revealed that cardiomyocyte
attachment depended on the surface coating material and the
length of the seeding period (Fig. 1A,B). At 6 and 18 h a signiﬁcantly
higher number of cardiomyocytes was attached on Npnt compared
to gelatin. However, there was no difference to the positive control
ﬁbronectin. In addition, spreading of cardiomyocytes was clearly
visible on Npnt and ﬁbronectin but not on gelatin (Fig. 1A). At 48 h
the number of attached cardiomyocytes was similar among the
different matrices. These data suggest that Npnt is a goodmatrix for
cardiomyocyte attachment.
In the adult heart cardiomyocytes cover around 75% of the heart
volume. However, 50%e70% of the cells in the heart are non-
myocytes. The main cell types are ﬁbroblasts, endothelial cells,
and vascular smooth muscle cells [29,30]. One goal in tissue engi-
neering is to generate a tissue patch that is as similar as possible to
cardiac tissue. Thus, it is important to determine if cardiac cells
other than cardiomyocytes can attach to Npnt. Our data demon-
strate that non-myocyte attachment was neither dependent on
time nor on the type of matrix. The majority of non-myocytes
(troponin I-negative) was attached at 6 h (Fig. 1A,C). In car-
diomyocyte cultures we found at 44 h beside cardiomyocytes
(orange and red arrow) also vascular smooth muscle cells (SMA-
positive and troponin I-negative, yellow arrow) (Fig. 2A). To test
how well non-myocytes attach to Npnt we seeded freshly isolated
cardiac cells for 2 h. Immunostaining analyses demonstrated that
there are only very few cardiomyocytes attached but not spread yet
(Fig. 2B, orange arrow). In contrast, vascular smooth muscle cells
(SMA-positive and troponin I-negative, yellow arrow) andG
el
at
in
N
pn
t
A
Fi
br
on
ec
tin
6 h 418 h
Troponin I/DAPI Troponin I/DAPI Tropon
Fig. 1. Cardiomyocytes attachment on Npnt. (A) Cardiomyocyte-enriched cells seeded 6, 1
diomyocytes, green) and DAPI (nuclei, blue). Scale bars: 50 mm (B, C) Quantiﬁcation of attach
signiﬁcant). (For interpretation of the references to colour in this ﬁgure legend, the readerendothelial cells (CD31- or Isolectin-positive, green arrow) were
attached on Npnt-coated coverslips and spread (Fig. 2B,C).
In conclusion, our data demonstrate that Nephronectin is not
only a good substrate for cardiomyocyte attachment but also for
other cellular components of the heart.
3.2. Metabolic activity
MTT assays were performed to better evaluate the cyto-
compatibility of Npnt. This assay is an indirect measurement of the
cellular metabolic activity and was performed on neonatal car-
diomyocytes cultured for up to 8 days on the indicated 2D
substrates. Cardiomyocyte cultures grown on Npnt and ﬁbronectin
exhibited a similar metabolic activity at all examined time points,
which was signiﬁcantly higher at days 2 and 4 compared to the
activity of cardiomyocytes grown on gelatin (Fig. 3A). After 6 days
of culture we did not observe any signiﬁcant difference among the
cells grown on gelatin, Npnt and ﬁbronectin in regards to cellular
activity and the ration of cardiomyocytes to non-myocytes
(Fig. 3A,B). In summary, Npnt has in comparison to ﬁbronectin no
negative effect on the metabolic activity of cardiomyocytes.
3.3. RGD-dependent cell attachment
Similar to ﬁbronectin, Npnt contains an RGD sequence and it has
been shown that this RGD sequence can bind with a number of
integrin receptors [31,32]. In contrast, gelatin does not have any
RGD sequence. Several studies have demonstrated that the RGD
sequence in natural as well as synthetic molecules stimulate cell
attachment and spreading via activation of cell surface integrin
receptors [33]. To investigate whether the superior attachment8 h
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Fig. 2. Non-myocyte attachment on Npnt. (A) Neonatal rat cardiomyocyte-enriched cells seeded on Npnt for 44 h were stained with anti-troponin I (cardiomyocytes, green) and
anti-smooth muscle a-actin (SMA) antibodies (marks smooth muscle cells and a subpopulation of cardiomyocytes, red) and with DAPI (nuclei, blue). Yellow arrow: smooth muscle
cell (SMA-positive, troponin I-negative). Orange arrow: mature cardiomyocyte (troponin I-positive). Red arrow: less matured cardiomyocyte (SMA-positive, troponin I-positive).
(B) Freshly isolated neonatal rat cardiac cells seeded for 2 h were stained as in A. Orange arrow: attached but not spread cardiomyocyte (troponin I-positive). Yellow arrow: smooth
muscle cell (SMA-positive, troponin I-negative). (C) Endothelial cells were identiﬁed by CD31 (red) or isolectin staining (green, combined with Differential Interference Contrast,
DIC). Nuclei were visualized with DAPI. Scale bars: 50 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
C. Patra et al. / Biomaterials 33 (2012) 4327e43354330properties of Npnt and ﬁbronectin compared to gelatin are due to
their RGD sequences, we performed integrin receptor blocking
assays by using RGDS peptides. In order to block all integrin
receptors, we incubated cardiomyocyte-enriched cells with RGDS
peptides for 30 min at 37 C prior to cell seeding. RGES peptides
were used as a control. MTT assays were performed to determine
cellular activity after 24 and 48 h of seeding. We set the relative
metabolic activity as 100% for the cells incubated with RGES
(negative control) for each substrate independently. The cellular
metabolic activity of cells cultured on gelatin was not affected by
incubation with RGDS or RGES peptides (Fig. 4A,B). In contrast,
there was a signiﬁcant reduction in the activity of cardiomyocytes
seeded on Npnt (100 5.8% to 72.6 7.1%, p< 0.05) and ﬁbronectin
(100  6.1% to 70.3  3.9%, p < 0.05) at 24 h (Fig. 4A). At 48 h we
observed still a weak effect of the RGDS peptide but the effect was
not signiﬁcant (Fig. 4B). In summary, our data suggest that the
cellular activity of cardiomyocytes on Npnt depends on its RGD
sequences.
The RGD sequence can modulate cell adhesion properties
[34,35]. Therefore, the reduced metabolic activity after integrin
receptor blocking might be due to reduced numbers of attached
cardiomyocytes. To investigate the effects of integrin blocking on
cardiomyocytes attachment, RGDS-treated cells were allowed toattach for 24 h and were subsequently stained for cardiomyocyte-
speciﬁc actinin to determine the number of attached car-
diomyocytes. Our quantitative analyses revealed that signiﬁcantly
reduced numbers of cardiomyocytes attached on Npnt after RGDS
treatment (Fig. 4C,D). However the number of attached car-
diomyocytes on gelatin and ﬁbronectin was not affect by RGDS
treatment. In addition, spreading of cardiomyocytes on Npnt as
well as ﬁbronectin was affected by integrin blocking.
3.4. Induction of cell cycle activity by growth factors
To further demonstrate that Npnt has no negative effect on
cardiomyocytes we tested their responsiveness to extracellular
stimuli. To explore the effect of growth factors on the car-
diomyocytes seeded on different matrices, we have stimulated
cardiomyocytes either with horse serum (HS) or ﬁbroblast growth
factor 1 (FGF1) along with an inhibitor of the mitogen-activated
protein kinase p38 (p38i) that are known to induce cell cycle
activity [36]. Stimulationwith HS results usually in a low activation
of DNA synthesis in cardiomyocytes seeded on gelatin. Quantitative
analyses indicated, that there is a signiﬁcant increase of BrdU-
positive cardiomyocytes seeded on Npnt (21.6  5.3%) compared
to gelatin (11.4  3.1%). The number of cardiomyocytes
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C. Patra et al. / Biomaterials 33 (2012) 4327e4335 4331incorporating BrdU on Npnt was comparable to cardiomyocytes
seeded on ﬁbronectin (25.5  3.8%) (Fig. 5A,B). Stimulation with
FGF1/p38i is a strong inducer of cardiomyocyte cell cycle activity
and induced BrdU incorporation in 28.2  5.3% of cardiomyocytes
seeded on gelatin (Fig. 5A,C). Stimulation of cardiomyocytes seeded
on Npnt or ﬁbronectin was signiﬁcantly more effective (45.5  7.4%
and 45.3  7.6%, respectively) (Fig. 5A,C). Taken together, car-
diomyocytes attached on Npnt responded well to extracellular
stimuli.3.5. Connexin 43 expression and contractility
The contractile force of an engineered cardiac tissue is a good
indicator for the cardiac tissue quality. It depends amongst others
on well-differentiated sarcomeres that are aligned in parallel and
electrical cell-to-cell coupling enabling synchronous contractions.
Cardiomyocyte grown on Npnt and ﬁbronectin displayed at 2 days
clearly visible aligned sarcomeres based on actinin and troponin I
expression (Fig. 6A). In contrast, the sarcomeric structure in car-
diomyocytes grown on gelatin were mainly not aligned and
appeared immature.
The gap junctional protein connexin 43 is essential for electrical
signal propagation between cardiomyocytes [37]. We observed that
cardiomyocytes grown on Npnt and ﬁbronectin expressed high
amounts of connexin 43 along their intercellular junctions (Fig. 6B).
In contrast, connexin 43 expression at the intercellular junctions of
cardiomyocytes grown on gelatin remained low or non-detectable.
Quantitative analysis of the beating frequency indicated that thenumber of contractionerelaxation cycles was signiﬁcantly higher
in cardiomyocytes grown on Npnt than on ﬁbronectin or gelatin
(Fig. 6C). In accordance to the connexin 43 expression, car-
diomyocytes seeded on gelatin showed independent focal beating
whereas cardiomyocytes seeded on Npnt or ﬁbronectin contracted
synchronously (Supplementary Movies 1e3). These data demon-
strate that Npnt promotes intercellular communication, sarcomere
maturation and alignment as well as synchronous contractions.
Supplementary video related to this article can be found at doi:
10.1016/j.biomaterials.2012.03.021.3.6. nppa and nppb expression
The quality of an engineered cardiac tissue depends on the
maturity of the seeded cardiomyocytes. Thus it is important that
the scaffold material used for tissue engineering maintains or even
promotes maturation of cardiomyocytes. The molecular phenotype
of the cells in our cultures was investigated by measuring the
relative levels of mRNA for natriuretic peptide precursor nppa and
nppb. 18S-RNA levels were used for normalizing gene expression
data. Fetal heart ventricles express higher levels of nppa and nppb
than adult ventricles. Ventricular reexpression of nppa in adults is
associated with ventricular hypertrophy. Therefore, nppa and nppb,
which are preferentially expressed in atrial, immature ventricular,
or hypertrophic ventricular tissue but not in mature, healthy
ventricular tissue were used as an indicator for cardiomyocyte
maturation [38]. A semi-quantitative gene expression analyses
indicated that the expression of nppa and nppb were signiﬁcantly
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Fig. 6. Npnt promotes intercellular communication and contractility. (A) Representative immunoﬂuorescence images of 2 days-cultured cardiomyocytes stained either for sar-
comeric a-actinin (cardiomyocytes, green) or troponin I (cardiomyocytes, green). Nuclei were visualized with DAPI (blue). Cardiomyocytes seeded on Npnt contain well-established
and aligned sarcomeres (yellow arrows). (B) Representative immunoﬂuorescence images of cardiomyocytes seeded on different matrices and subsequently stained with anti-
sarcomeric a-actinin (cardiomyocytes, green) and anti-connexin 43 antibodies (intercellular junctions, red) and with DAPI (nuclei, blue). Importantly cardiomyocytes on Npnt
express connexin 43 (yellow arrow heads) indicating well-established intercellular communication. (C) Quantitative analysis of the cardiomyocyte beating frequency 48 h after
seeding (n ¼ 3, mean  SEM, **: p < 0.01). Scale bars: 20 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
C. Patra et al. / Biomaterials 33 (2012) 4327e4335 4333reduced in cardiomyocytes cultured on gelatin compared to
expression levels in freshly isolated non-cultured neonatal car-
diomyocytes at 2 days of culture (Fig. 7A). Real time PCR conﬁrmed
this result and demonstrated that cardiomyocytes cultured on
ﬁbronectin express higher levels of nppa and nppb. In contrast, nppa
and nppb expression levels of cardiomyocytes cultured on Npnt
were not signiﬁcantly different from the expression levels in freshly
isolated non-cultured cardiomyocytes (Fig. 7B). Our data suggest
that Npnt maintains the maturation state of cardiomyocytes. This is
further supported by the observation that most cardiomyocytes
cultured on Npnt did not express alpha smooth muscle actin (2A).
During in vivo cardiogenesis, cardiomyocytes express different
actin isoforms: skeletal (SKA), cardiac (CAA) and smooth muscle
(SMA) alpha actin. SMA marks the onset of cardiomyocyte differ-
entiation. Later in development it is sequentially replaced by SKA
and CAA isoforms [39,40]. When cardiomyocytes from neonatal oradult rats are cultured in vitro, they usually re-express SMA, which
is a sign of dedifferentiation and most importantly affects the
contractile properties of the cells [41e43]. Our data demonstrate
that Npnt prevents the reexpression of SMA.
4. Discussion
Cardiac tissue engineering is a promising approach to partially
reverse cardiovascular diseases includingmyocardial infarction and
congenital heart disease. The goal is to generate ex vivo a tissue-like
structure that should be as similar to native myocardium as
possible. It should contain cardiomyocytes but also ﬁbroblasts,
endothelial cells, and vascular smooth muscle cells [29,30]. In order
to maximize the contractile force of cardiac patches they have to
contain a high number of cardiomyocytes, which are electrical
coupled, are mature containing aligned sarcomeres. In recent years
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Fig. 7. Cardiomyocytes seeded on Npnt express similar level of nppa and nppb as freshly isolated neonatal cardiomyocytes. (A,B) Semi-quantitative (A) and quantitative (B) PCR
analysis of nppa and nppb mRNA expression in freshly isolated neonatal cardiomyocytes (not cultured) or 2 days-cultured cardiomyocytes on different matrices. 18S-RNA was used
as loading control. Ladder indicates a size marker (n ¼ 3, mean  SEM, *: p < 0.05, ns: not signiﬁcant).
C. Patra et al. / Biomaterials 33 (2012) 4327e43354334a number of scaffold-forming materials have been used to generate
in vitro cardiac patches, but none of them reached the quality for
therapeutic application. One major limitation is the generated
contractile force. Forces of isolated native myocardium are
50 mN/mm2 [44]. Reported values for engineered cardiac patches
range between 0.05 and 2 mN/mm2 [45]. Thus, it is important to
identify materials that can enhance cardiomyocyte attachment,
maturation and electrical coupling.
Recently, it has been shown that the natural ECM of the heart
provides a suitable scaffold for cardiac tissue engineering [16].
Moreover, it has been shown that the ECM composition changes
during heart development, is required to maintain or acquire new
cellular functions and is crucial for directing tissue speciﬁcation.
Thus, it is important to characterize the natural components of the
cardiac ECM during development [17]. Especially the poor adhesive
properties of cardiomyocytes hampers the generation of cardiac
tissues. Thus, recent strategies in tissue engineering focus on
incorporating ECM-derived peptides into biomaterials in order to
mimic the natural matrix [15]. In this study we studied Npnt, which
we have recently shown to be developmentally regulated. The data
presented here suggest that Npnt has the potential to become
useful for cardiac tissue engineering. We have shown that all major
cellular components of the heart like cardiomyocytes, cardiac
ﬁbroblasts, vascular smooth muscle cells and endothelial cells can
attach and spread on Npnt. Cardiomyocytes attached and spread
markedly faster on Npnt than on gelatin. Our data suggest that this
is in part due to the presence of the integrin binding RGD sequence
in Npnt [46]. In addition, cardiomyocytes grown on Npnt exhibited
a matured contractile apparatus with well-aligned sarcomeres.
Connexin 43 expression data suggest moreover that the cells were
electrical coupled. Consequently, cardiomyocytes on Npnt con-
tracted synchronously and exhibited a higher beating frequency
than cardiomyocytes on gelatin or ﬁbronectin. Finally, we analyzed
the expression of nppa, nppb and SMA in order to assess the
differential status of cardiomyocytes [38,41e43]. Cardiomyocytes
grown Npnt exhibited the same expression pattern as freshly iso-
lated cardiomyocytes (nppa and nppb) or did not re-express fetal
genes (SMA). Taken together, our data indicate that Npnt maintains
differentiation, promotes sarcomere maturation as well as elec-
trical signal propagation and consequently cardiomyocyte
contractility.
In the future it will be important to investigate if Npnt or Npnt
peptides can be used for surface modiﬁcations or bulkmodiﬁcations of 3D scaffolds to provide a more natural microen-
vironment to generate advanced cardiac tissue patches.5. Conclusions
Nephronectin (Npnt) enables at least in part due to its RGD
domain the efﬁcient attachment of the main cell types of the heart:
cardiomyocytes, endothelial cells, and vascular smooth muscle
cells. Cardiomyocytes growing on Npnt contain mature well-
aligned sarcomeres, express connexin 43 and couple electrically
with each other resulting in synchronous beating at least for 8 days.
Moreover, most cardiomyocytes on Npnt were SMA-negative sup-
porting the notion that Npnt maintains the differentiation state of
the cells. Npnt was superior to ﬁbronectin, which is considered as
one of the best cardiac adhesive. Cardiomyocytes on Npnt displayed
a higher beating frequency and maintained on a molecular level
a more differentiated phenotype. Our ﬁndings suggest that Npnt is
a cardiac adhesive molecule with the potential to improve cardiac
tissue engineering. This study underlines the importance to eluci-
date the composition of the cardiac ECM during development to
reveal ECM components to further optimize the fabrication of
scaffolds for the generation of cardiac patches.Disclosure statement
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